Detection of Periodontal Microorganisms in Coronary Atheromatous Plaque Specimens of Myocardial Infarction Patients: A Systematic Review and Meta-analysis
Overview
Affiliations
Background: Microbial translocation from inflamed periodontal pockets into coronary atheroma via systemic circulation is one of the proposed pathways that links periodontitis and myocardial infarction (MI). The purpose of this systematic review is to determine the reported prevalence of periodontal microorganisms in coronary atheroma and/or aspirated clot samples collected from MI patients with periodontal disease.
Methodology: The "Preferred Reporting Items for Systematic Reviews and Meta-Analyses" (PRISMA) guidelines were followed. Six databases were systematically searched using Medical Subject Headings/Index and Entree terms. After a thorough screening, fourteen publications spanning over ten years (2007-2017) were eligible for this systematic review and meta-analysis.
Results: Out of 14 included studies, 12 reported presence of periodontal bacterial DNA in coronary atherosclerotic plaque specimens. Overall, Porphyromonas gingivalis and Aggregatibacter actinomycetemcomitans were the most frequently detected periodontal bacterial species. Meta-analysis revealed that the prevalence of P. gingivalis was significantly higher than A. actinomycetemcomitans in coronary atheromatous plaque samples. Apart from periodontal microbes, DNA from a variety of other microbes e.g. Pseudomonas fluorescens, Streptococcus species, Chlamydia pneumoniae were also recovered from the collected samples.
Conclusion: Consistent detection of periodontal bacterial DNA in coronary atheroma suggests their systemic dissemination from periodontal sites. It should further be investigated whether they are merely bystanders or induce any structural changes within coronary arterial walls.
Gorr S, Chen R, Abrahante J, Joyce P PLoS One. 2024; 19(10):e0312200.
PMID: 39446776 PMC: 11500903. DOI: 10.1371/journal.pone.0312200.
Periodontitis impacts on thrombotic diseases: from clinical aspect to future therapeutic approaches.
Ge J, Zhu X, Weng C, Yuan D, Zhao J, Zhao L Int J Oral Sci. 2024; 16(1):58.
PMID: 39402049 PMC: 11473739. DOI: 10.1038/s41368-024-00325-9.
A Comprehensive Review of the Triangular Relationship among Diet-Gut Microbiota-Inflammation.
Randeni N, Bordiga M, Xu B Int J Mol Sci. 2024; 25(17).
PMID: 39273314 PMC: 11394685. DOI: 10.3390/ijms25179366.
Cardiovascular disease therapeutics via engineered oral microbiota: Applications and perspective.
Zhen W, Wang Z, Wang Q, Sun W, Wang R, Zhang W Imeta. 2024; 3(3):e197.
PMID: 38898992 PMC: 11183164. DOI: 10.1002/imt2.197.
Lund Haheim A Front Oral Health. 2024; 5:1348946.
PMID: 38774039 PMC: 11107091. DOI: 10.3389/froh.2024.1348946.